Published in Cancer Weekly, December 4th, 1995
The committee's recommendation, although not binding, will be considered by the FDA in completing its review of the company's application to obtain expanded use for Leukine.
Immunex filed a product license application supplement with the FDA seeking approval to market Leukine for use in PBSC mobilization and transplantation in...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.